Reporting owner · CIK 0001765021

MPM BioVentures 2014 LLC

Visual SEC Form 4 history across 1 companies, 9 transactions and 3 filings.

10%Entrada Therapeutics, Inc.
Open-market mix
Latest filingSep 03, 2026, 11:21 PM
Filings3Form 4 records
Buying$00 purchases
Selling$1.7M9 sales
Net value−$1.7MBuys minus sells
Companies11 securities
Most recentSep 03, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-106Aug 263Sep 26

Net value flow

Buys minus sells

Aug 26
−$1.1M
Sep 26
−$617.4K

Transaction texture

Ownership and ticket size

Average P/S size$188.3K
Median P/S size$200K
Direct0
Indirect9
Sep 03, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern6Repeat Sellerpattern5

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Entrada Therapeutics, Inc. on Sep 03, 2026 valued at $231,326.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Entrada Therapeutics, Inc. on Sep 03, 2026 valued at $231,326.

Review SEC filing

Associated companies

Visual map of known reporting history

TRDAEntrada Therapeutics, Inc.9 transactions · latest Sep 03, 2026, 11:21 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TRDAMPM BioVentures 2014 LLC
10%
sale32.2k-$23.1MS
Cluster Selling Repeat Seller
0.0%09/0309/03
TRDAMPM BioVentures 2014 LLC
10%
sale25.1k-$18.0MS
Cluster Selling Repeat Seller
0.0%09/0309/02
TRDAMPM BioVentures 2014 LLC
10%
sale29.0k-$20.5MS
Cluster Selling Repeat Seller
0.0%09/0309/01
TRDAMPM BioVentures 2014 LLC
10%
sale44.2k-$30.9MS
Cluster Selling Repeat Seller
0.0%08/3108/31
TRDAMPM BioVentures 2014 LLC
10%
sale3.73k-$2.61MS
Cluster Selling Repeat Seller
0.0%08/3108/28
TRDAMPM BioVentures 2014 LLC
10%
sale38.9k-$28.0MS
Cluster Selling Repeat Seller
0.0%08/3108/27
TRDAMPM BioVentures 2014 LLC
10%
sale14.5k-$10.2MS
Cluster Selling Repeat Seller
—08/2708/26
TRDAMPM BioVentures 2014 LLC
10%
sale26.5k-$19.9MS
Cluster Selling Repeat Seller
—08/2708/25
TRDAMPM BioVentures 2014 LLC
10%
sale21.6k-$15.8MS
Cluster Selling
—08/2708/24

MPM BioVentures 2014 LLC Insider Activity FAQ

SEC Form 4 context

Who is MPM BioVentures 2014 LLC?

MPM BioVentures 2014 LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001765021.

Which companies has MPM BioVentures 2014 LLC reported transactions for?

Entrada Therapeutics, Inc.

When was MPM BioVentures 2014 LLC's latest insider buy?

No open-market insider purchase is available for this period.

When was MPM BioVentures 2014 LLC's latest insider sale?

sale at Entrada Therapeutics, Inc. on Sep 03, 2026 valued at $231,326.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.